Use of cotinine to alleviate tobacco withdrawal syndrome

Details Use of cotinine to alleviate tobacco withdrawal syndrome Use of cotinine to alleviate tobacco withdrawal syndrome

1996-08-01

1998-05-05

Weddington, Kevin E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514813, 514909, A61K 3144

Patent

active

057475121

ABSTRACT:
A therapeutic method is provided to alleviate tobacco withdrawal syndrome and/or the symptoms of nicotine withdrawal, comprising administering an amount of cotinine or a pharmaceutically acceptable salt thereof to a human in need of such treatment, which amount is effective to reduce or eliminate at least one of the symptoms of tobacco withdrawal syndrome or nicotine withdrawal.

REFERENCES:
patent: 3870794 (1975-03-01), Hutchinson et al.
patent: 5573774 (1996-11-01), Keenan
patent: 5596007 (1997-01-01), Keenan et al.
patent: 5612357 (1997-03-01), Keenan et al.

Affiliated with

Also associated with

Rating

Use of cotinine to alleviate tobacco withdrawal syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of cotinine to alleviate tobacco withdrawal syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cotinine to alleviate tobacco withdrawal syndrome will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-55071